Supporting Information

Total Page:16

File Type:pdf, Size:1020Kb

Supporting Information Supporting Information Iftakhar-E-Khuda et al. 10.1073/pnas.1602357113 SI Methods P (Roche) and 0.8 mg/mL neutral protease (Worthington Mice. C57BL/6J (stock 000664) WT, and MSR KO (B6.Cg- Biochemical) for 45 min at 37 °C. The isolated cells were cul- tm1Csk tured in gelatin-coated flasks in complete mouse endothelial cell Msr1 /J (stock 006096) mice were purchased from The − − medium/w kit (Cell Biologics) for 7 d. Thereafter, CD45 /CD11b / Jackson Laboratory. All animal experiments were approved by + + + the Ethical Committee for Animal Experimentation in Finland. podoplanin /CD31 /Lyve-1 cells were low-pressure sorted using FACSAria IIu fitted with a 100-μm tip. Sorted LECs were seeded Antibodies. Detailed information of the antibodies used is given in at a concentration of 5 × 105 cells/cm2 andculturedfor7d. Table S3. Microarray Analysis. RNA amplification, labeling, and cDNA LCMP. Inguinal, axillary, brachial lymph nodes (LNs) from C57BL/ microarray hybridization and gene expression analyses were 6J mice aged 8 wk were used for the isolation of LECs from the SS performed at the Miltenyi Biotec Genomic Services (Miltenyi and LS. LNs were collected in Rnase-free phosphate buffer saline Biotec). The sorted cells in SuperAmp Lysis Buffer were sub- containing 1 unit/μL SUPERase-In (Applied Biosystem) and jected to SuperAmp RNA amplification based on a global PCR thereafter, placed onto a layer of OCT containing 20 μg/mL protocol using mRNA-derived cDNA according to Miltenyi vanadyl ribonucleoside complex (Sigma-Aldrich) solution. More Biotec’s undisclosed procedure. The integrity of the cDNA was solution was added over the LNs until they were completely checked with the Agilent 2100 Bioanalyzer platform (Agilent covered. The filled cryomolds were immediately frozen in dry-ice Technologies). The average length of the highly amplified cDNA chilled isopentane and stored in a −70 °C freezer until use. products ranged between 200 and 1,000 bp. The cDNAs (250 ng) Alexa Fluor 488 anti-mouse CD31 (Biolegend) and PE-Texas were used as templates for Cy3 labeling using Miltenyi Biotec’s red anti-mouse F4/80 (Invitrogen) antibodies were applied onto undisclosed protocol. The Cy3-labeled cDNAs were hybridized the frozen sections of the LNs for 3 min at 4 °C. After washing, overnight (17 h, 65 °C) to Agilent Whole Mouse Genome Oligo the sections were dehydrated through ascending concentrations Microarrays 8× 60 K using Agilent’s recommended hybridization of ice cold ethanol [70%, 95%, and 100% (vol/vol)] for 10 s each chamber and oven. Fluorescence signals of the hybridized Agi- and finally in xylene for 10 s. lent Microarrays were detected using Agilent’s Microarray Scanner Microscopic observations of the cells were performed using a System (Agilent Technologies). The Agilent Feature Extraction Zeiss microscope with filter set 25 (Zeiss) and LCMP was con- Software was used to read out and process the microarray image ducted on a PALM microbeam instrument including Palm-Robo files. The software determines feature intensities (including back- version 3 software. To maximize the collection of the right cells, in ground subtraction), rejects outliers, and calculates statistical + the SS only discrete CD31 cells were collected. In the LS area, confidences. The microarray data produced in this study has been the blood vessels stain much brighter for CD31 than do LECs. deposited to GEO archive (GSE 68371). Moreover, LS lymphatics can be morphologically discriminated In bioinformatics analyses, the intensity data were background from the blood vessels. SS and LS endothelial cells were col- corrected and quantile normalization was conducted between the lected based on these characteristics using a 40× objective and arrays. The normalized intensities were log2 transformed and the fluorescence filter. LCMP of the labeled cells was performed used as a basis for further analysis. Interexperiment correlation under bright-field optics. The following settings were used for analysis of normalized log2 intensities was performed using Eu- the microdissection procedure: dissection method, Robo LPC; clidean distance metric. The differential gene expression be- UV energy, 50–65; UV focus, 45–50; and cutting speed, 20. tween the SS and the LS of the LCM samples was tested with a Microdissected cells were collected to adhesive caps (Zeiss); one-way ANOVA and an adjusted P value was calculated by the before their use, the caps were irradiated with UV (254 nm) for method of Benjamini and Hochberg (24). All samples of the SS 30 min. Five cells were isolated per slide to minimize the time and LS populations regardless of the isolation method were (15–20 min) and maximize the quality of RNA. Altogether 50 further used as a test and reference group, respectively, by per- cells were collected per experiment. The cells were collected forming Student’s t test (two tailed). The differentially expressed into the superamp lysis buffer (Miltenyi Biotec), incubated at 45 °C (DE) genes were selected requiring an absolute fold-change >2 for 10 min, and thereafter stored at −40 °C. and a P < 0.05. For stringent selection, the magnitude of the expression difference was at least eightfold. A detection P value Isolation and Sorting of LECs. Peripheral LNs and MLNs from 12 (Rosetta resolver error model) (25) was also calculated for each mice were pooled and digested in a freshly prepared enzyme mix reporter to indicate whether the signal is reliable or not. This [PBS containing 25 μg/mL liberase TM research grade (Roche) P value was used in further filtering of the data to allow only and 100 μg/mL DNase I (Roche)]. For cell sorting, the following records with the majority of samples fulfilling the detection cri- antibodies were used: APC-conjugated lineage (CD3e, CD11b, teria (detection P < 0.01) in the group with higher expression. CD45R/B220, erythroid cells, Ly-6G, and Ly-6C) mixture, with Functional grouping analyses were performed using the dif- an isotype control (BD Pharmingen), PE anti-CD73 (BD Phar- ferentially expressed genes as input gene populations. The an- mingen), and PE/Cy7 anti-podoplanin (Biolegend). Seven-AAD notations used were derived from Gene Ontology databases (Calbiochem) was used to exclude dead cells. The 106 cells/100 μL and various other pathway resources curated by Miltenyi Biotec. were incubated with 1 μL of each antibody for 15 min at 4 °C The differentially expressed reporters were tested for significant before acquisition on a FACSAria IIu (BD Bioscience). A total of enrichments of annotations using the TreeRanker software 1,200 cells were sorted into FCS-coated FACS tubes con- (Miltenyi Biotec). The frequency of the association of a category taining RPMI-1640 and 20% (vol/vol) FCS; cell purity was with the input reporter set was compared with that of a back- more than 98%. The gating was always done based on the ground set (Agilent 8× 60 K array genes). P values were com- stainings with negative control antibodies. puted by Fisher’s exact test with Benjamini–Hochberg correction For primary cell cultures, mouse peripheral and mesenteric for multiple testing. Values ≤0.05 indicate a significant enrichment LNs were digested with PBS containing 0.2 mg/mL collagenase of the respective category relative to the background (all reporters Iftakhar-E-Khuda et al. www.pnas.org/cgi/content/short/1602357113 1of10 with a gene ID (Entrez) of the Agilent Whole Mouse Genome Flow Cytometric Analyses. Enzyme digestions and antibody staining Oligo Microarray 8× 60 K). The data were further analyzed using of LNs were performed as described in Isolation and Sorting of GENE-E analysis platform (https://www.broadinstitute.org/cancer/ LECs. The skin was digested for 45 min in a freshly prepared software/GENE-E/). enzyme mix (PBS containing 8 mg/mL collagenase IV from Sigma and 100 μg/mL DNase from Roche). The following pri- Immunohistochemical Analyses. Frozen sections were stained with mary, secondary, and isotype-control antibodies were used for primary antibodies: rat anti-mouse MSR1/CD204 (Lifespan stainings: APC-Cy7 rat anti-mouse CD45 (BD Pharmingen), Bioscience), rat anti-mouse Siglec-1/CD169 (AbD Serotec), rat APC-Cy7 rat anti-mouse CD11b (BD Pharmingen), PE/Cy7 Sy- anti-mouse EMCN (EMD Millipore), rabbit anti-mouse Lyve-1 rian hamster anti-mouse podoplanin (Biolegend), APC rat anti- (ReliaTech), Syrian hamster anti-mouse podoplanin/gp36 (Abcam), mouse CD31 (Biolegend), PE-conjugated rat anti-mouse Lyve-1 and rat anti-mouse PLVAP-1 (Meca 32, gift from Eugene Butcher, (R&D Systems), PE rat IgG2A κ-isotype control antibody (BD Stanford University, Stanford, CA). The second stage reagents Pharmingen), rat anti-mouse CD204 (Lifespan Bioscience), rat were: Alexa Fluor 546 goat anti-rat IgG (H+L) (Invitrogen), Alexa anti-mouse CD169 (AbD Serotec), rat anti-mouse EMCN (EMD Fluor 488 goat anti-rabbit IgG (H+L) (Invitrogen), Alexa Fluor Millipore), eFluor 660 anti-mouse EMCN (eBioscience), FITC- 546 goat anti-rabbit IgG (H+L) (Invitrogen), and Alexa Fluor 488 conjugated rat IgG1 λ-isotype control (Biolegend), FITC-conjugated goat anti-hamster IgG (H+L) (Invitrogen). The following direct rat IgG2A κ-isotype control (BD Pharmingen), FITC-conjugated rat conjugates were used: Alexa Fluor 488-conjugated rat anti-mouse IgG2B κ-isotype control (BD Pharmingen), and FITC-conjugated CD204 (BIO-RAD) and Alexa Fluor 488-conjugated rat anti- goat anti-rat IgG (whole molecule) (Sigma). Cells were analyzed with mouse Lyve-1 (R&D Systems), Alexa Fluor 647 rat anti-mouse FACSAria IIu and LSR Fortessa (both BD Biosciences) using CD4 (BD), Pacific Blue rat anti-mouse CD45R (BD), and Alexa FlowJo software (Tree Star). Fluor 488 rat anti-mouse CD8 (BD) or Alexa Fluor 488 rat anti- mouse CD31 (Biolegend). Finally, the sections were mounted in Adhesion Assays. Ex vivo. ProlongGold anti-fade reagent (Molecular Probes) and images In principle the adhesion assays were performed as de- were acquired using an Olympus BX60 microscope or an LSM 780 scribed earlier (26).
Recommended publications
  • Stem Cell Factor Is Selectively Secreted by Arterial Endothelial Cells in Bone Marrow
    ARTICLE DOI: 10.1038/s41467-018-04726-3 OPEN Stem cell factor is selectively secreted by arterial endothelial cells in bone marrow Chunliang Xu1,2, Xin Gao1,2, Qiaozhi Wei1,2, Fumio Nakahara 1,2, Samuel E. Zimmerman3,4, Jessica Mar3,4 & Paul S. Frenette 1,2,5 Endothelial cells (ECs) contribute to haematopoietic stem cell (HSC) maintenance in bone marrow, but the differential contributions of EC subtypes remain unknown, owing to the lack 1234567890():,; of methods to separate with high purity arterial endothelial cells (AECs) from sinusoidal endothelial cells (SECs). Here we show that the combination of podoplanin (PDPN) and Sca-1 expression distinguishes AECs (CD45− Ter119− Sca-1bright PDPN−) from SECs (CD45− Ter119− Sca-1dim PDPN+). PDPN can be substituted for antibodies against the adhesion molecules ICAM1 or E-selectin. Unexpectedly, prospective isolation reveals that AECs secrete nearly all detectable EC-derived stem cell factors (SCF). Genetic deletion of Scf in AECs, but not SECs, significantly reduced functional HSCs. Lineage-tracing analyses suggest that AECs and SECs self-regenerate independently after severe genotoxic insults, indicating the per- sistence of, and recovery from, radio-resistant pre-specified EC precursors. AEC-derived SCF also promotes HSC recovery after myeloablation. These results thus uncover heterogeneity in the contribution of ECs in stem cell niches. 1 The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY 10461, USA. 2 Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461, USA. 3 Department of Systems and Computational Biology, Albert Einstein College of Medicine, New York, NY 10461, USA.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • The Purinergic Receptor P2Y, G-Protein Coupled, 2 (P2RY2) Gene Associated with Essential Hypertension in Japanese Men
    Journal of Human Hypertension (2010) 24, 327–335 & 2010 Macmillan Publishers Limited All rights reserved 0950-9240/10 $32.00 www.nature.com/jhh ORIGINAL ARTICLE The purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene associated with essential hypertension in Japanese men Z Wang1,2, T Nakayama1,3, N Sato1, Y Izumi3, Y Kasamaki4, M Ohta4, M Soma5, N Aoi1, Y Ozawa4 andYMa2 1Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan; 2Department of Cardiovascular Medicine, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, PR China; 3Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan; 4Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan and 5Division of General Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan P2RY2 has an important function in the regulation of respectively). Logistic regression showed that for blood pressure by activating adenosine triphosphate the total and men groups, the TG þ TT genotype of (ATP). The aim of this study was to investigate the asso- rs4944831 was more prevalent in EH patients than in the ciation between the human P2RY2 gene and essential controls (P ¼ 0.026 and 0.011, respectively). For men, the hypertension (EH) through a haplotype-based case– overall distribution of the haplotype (SNP2-SNP4-SNP5) control study that included two gender groups. The 273 was significantly different between the EH patients EH patients and 255 age-matched controls were geno- and the controls (P ¼ 0.006). As compared with controls, typed for five single-nucleotide polymorphisms (SNPs) the frequency of the T-A-G haplotype was significantly of the human P2RY2 gene (rs4944831, rs1783596, higher, whereas the T-C-G haplotype was significan- rs4944832, rs4382936 and rs10898909).
    [Show full text]
  • Genome-Wide Prediction of Small Molecule Binding to Remote
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.236729; this version posted August 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Genome-wide Prediction of Small Molecule Binding 2 to Remote Orphan Proteins Using Distilled Sequence 3 Alignment Embedding 1 2 3 4 4 Tian Cai , Hansaim Lim , Kyra Alyssa Abbu , Yue Qiu , 5,6 1,2,3,4,7,* 5 Ruth Nussinov , and Lei Xie 1 6 Ph.D. Program in Computer Science, The Graduate Center, The City University of New York, New York, 10016, USA 2 7 Ph.D. Program in Biochemistry, The Graduate Center, The City University of New York, New York, 10016, USA 3 8 Department of Computer Science, Hunter College, The City University of New York, New York, 10065, USA 4 9 Ph.D. Program in Biology, The Graduate Center, The City University of New York, New York, 10016, USA 5 10 Computational Structural Biology Section, Basic Science Program, Frederick National Laboratory for Cancer Research, 11 Frederick, MD 21702, USA 6 12 Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel 13 Aviv, Israel 7 14 Helen and Robert Appel Alzheimer’s Disease Research Institute, Feil Family Brain & Mind Research Institute, Weill 15 Cornell Medicine, Cornell University, New York, 10021, USA * 16 [email protected] 17 July 27, 2020 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.236729; this version posted August 5, 2020.
    [Show full text]
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • Goat Anti-JAM2 / JAMB / CD322 Antibody Peptide-Affinity Purified Goat Antibody Catalog # Af1576a
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 Goat Anti-JAM2 / JAMB / CD322 Antibody Peptide-affinity purified goat antibody Catalog # AF1576a Specification Goat Anti-JAM2 / JAMB / CD322 Antibody - Product Information Application WB Primary Accession P57087 Other Accession NP_067042, 58494, 67374 (mouse), 619374 (rat) Reactivity Human Predicted Mouse, Rat, Dog, Cow Host Goat Clonality Polyclonal Concentration 100ug/200ul Isotype IgG Calculated MW 33207 Goat Anti-JAM2 / JAMB / CD322 Antibody - AF1576a (0.5 µg/ml) staining of Human Additional Information Heart lysate (35 µg protein in RIPA buffer) with (B) and without (A) blocking with the Gene ID 58494 immunising peptide. Primary incubation was 1 hour. Detected by chemiluminescence. Other Names Junctional adhesion molecule B, JAM-B, Junctional adhesion molecule 2, JAM-2, Goat Anti-JAM2 / JAMB / CD322 Antibody - Vascular endothelial junction-associated Background molecule, VE-JAM, CD322, JAM2, C21orf43, VEJAM Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial Format cell sheets, forming continuous seals around 0.5 mg IgG/ml in Tris saline (20mM Tris cells and serving as a physical barrier to pH7.3, 150mM NaCl), 0.02% sodium azide, prevent solutes and water from passing freely with 0.5% bovine serum albumin through the paracellular space. The protein encoded by this immunoglobulin superfamily Storage gene member is localized in the tight junctions Maintain refrigerated at 2-8°C for up to 6 between high endothelial cells. It acts as an months. For long term storage store at adhesive ligand for interacting with a variety of -20°C in small aliquots to prevent immune cell types and may play a role in freeze-thaw cycles.
    [Show full text]
  • Activation of Hypermethylated P2RY1 Mitigates Gastric Cancer by Promoting Apoptosis and Inhibiting Proliferation
    Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation Yinggang Hua Xiamen University Medical College Long Li Xiamen University Medical College Liangliang Cai Zhongshan Hospital Xiamen University Guoyan Liu ( [email protected] ) Zhongshan Hospital Xiamen University Research Article Keywords: Diffuse type gastric cancer, DNA methylation 450K array, P2RY1 receptor, ERK signal pathway, Tumor suppressor gene Posted Date: July 26th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-351723/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/16 Abstract P2RY1 receptor is known to cause cancer by activating the ERK signal pathway, its DNA methylation status or even the corresponding regulatory mechanism remains unknown. In this study, DNA methylation chip was used to prole the genome-wide DNA methylation level in gastric cancer tissues. Proliferation and apoptosis of the SGC7901 gastric cancer cell line were determined after treatment with a selective P2RY1 receptor agonist, MRS2365. The promoter region of P2RY1 was found to be highly methylated with 4 hypermethylated sites (|Δβ value| >0.2) in diffuse gastric cancer and then were validated by bioinformatic analysis in TCGA database. Analysis of MRS2365-treated cells by annexin-V/PI staining and Caspase-3 activity assays indicated the induction of apoptosis in SGC7901 cells. P2RY1 receptor activation in human SGC7901 gastric cancer cells via the MRS2365 agonist induced apoptosis and reduced cell growth. High DNA methylation in the promoter region of P2RY1 may have contributed to the reduced expression of P2RY1’s mRNA, which is likely responsible for the “aggressive” nature of the diffuse type gastric cancer.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Reck and Gpr124 Activate Canonical Wnt Signaling To
    RECK AND GPR124 ACTIVATE CANONICAL WNT SIGNALING TO CONTROL MAMMALIAN CENTRAL NERVOUS SYSTEM ANGIOGENESIS AND BLOOD-BRAIN BARRIER REGULATION by Chris Moonho Cho A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland July 2018 © Chris Moonho Cho 2018 All rights reserved Abstract Canonical Wnt signaling plays a pivotal role in promoting central nervous system (CNS) angiogenesis and blood-brain barrier (BBB) formation and maintenance. Specifically, Wnt7a and Wnt7b are required for vascular development in the forebrain and ventral spinal cord. Yet, how these two ligands – among the 19 mammalian Wnts – are selectively communicated to Frizzled receptors expressed on endothelial cells (ECs) remains largely unclear. In this thesis, we propose a novel paradigm for Wnt specificity. We have identified two EC surface proteins – orphan receptor Gpr124, and more recently, GPI-anchored Reck (reversion-inducing cysteine-rich protein with Kazal motifs) – as essential receptor co-factors that assemble into a multi-protein complex with Wnt7a/7b and Frizzled for the development of the mammalian neurovasculature. Specifically, we show that EC-specific reduction in Reck impairs CNS angiogenesis and that EC-specific postnatal loss of Reck, combined with loss of Norrin, impairs BBB maintenance. We identify the critical domains of both Reck and Gpr124 that are required for Wnt activity, and demonstrate that these regions are important for ii direct binding and complex formation. Importantly, weakening this interaction by targeted mutagenesis reduces Reck-Gpr124 stimulation of Wnt7a signaling in cell culture and impairs CNS angiogenesis. Finally, a soluble Gpr124 probe binds specifically to cells expressing Frizzled (Fz), Wnt7a or Wnt7b, and Reck; and a soluble Reck probe binds specifically to cells expressing Fz, Wnt7a or Wnt7b, and Gpr124.
    [Show full text]
  • Targeting Lysophosphatidic Acid in Cancer: the Issues in Moving from Bench to Bedside
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by IUPUIScholarWorks cancers Review Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside Yan Xu Department of Obstetrics and Gynecology, Indiana University School of Medicine, 950 W. Walnut Street R2-E380, Indianapolis, IN 46202, USA; [email protected]; Tel.: +1-317-274-3972 Received: 28 August 2019; Accepted: 8 October 2019; Published: 10 October 2019 Abstract: Since the clear demonstration of lysophosphatidic acid (LPA)’s pathological roles in cancer in the mid-1990s, more than 1000 papers relating LPA to various types of cancer were published. Through these studies, LPA was established as a target for cancer. Although LPA-related inhibitors entered clinical trials for fibrosis, the concept of targeting LPA is yet to be moved to clinical cancer treatment. The major challenges that we are facing in moving LPA application from bench to bedside include the intrinsic and complicated metabolic, functional, and signaling properties of LPA, as well as technical issues, which are discussed in this review. Potential strategies and perspectives to improve the translational progress are suggested. Despite these challenges, we are optimistic that LPA blockage, particularly in combination with other agents, is on the horizon to be incorporated into clinical applications. Keywords: Autotaxin (ATX); ovarian cancer (OC); cancer stem cell (CSC); electrospray ionization tandem mass spectrometry (ESI-MS/MS); G-protein coupled receptor (GPCR); lipid phosphate phosphatase enzymes (LPPs); lysophosphatidic acid (LPA); phospholipase A2 enzymes (PLA2s); nuclear receptor peroxisome proliferator-activated receptor (PPAR); sphingosine-1 phosphate (S1P) 1.
    [Show full text]
  • Tolerance and M2 (Alternative) Macrophage Polarization Are Related Processes Orchestrated by P50 Nuclear Factor ␬B
    Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor ␬B Chiara Portaa,b, Monica Rimoldic, Geert Raesd, Lea Brysd, Pietro Ghezzie, Diana Di Libertof, Francesco Dielif, Serena Ghislettig, Gioacchino Natolig, Patrick De Baetselierd, Alberto Mantovanic,h, and Antonio Sicaa,b,1 aFondazione Humanitas per la Ricerca, 20089 Rozzano, Italy; bDipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche, University of Piemonte Orientale A. Avogadro, 28100 Novara, Italy; cIstituto Clinico Humanitas, Istituto di Ricovero e Cura a Carattere Scientifico, 20089 Rozzano, Italy; dLaboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, and Department of Molecular ad Cellular Interactions, 1050 Brussels, Belgium; eBrighton and Sussex Medical School, Brighton BN1 9PX, United Kingdom; fDipartimento di Biopatologia e Metodologie Biochimediche, Universita`di Palermo, 90134 Palermo, Italy; gDepartment of Experimental Oncology, European Institute of Oncology at IFOM-IEO Campus, 20139 Milan, Italy; and hUniversity of Milan, 20133 Milan, Italy Edited by Michael Karin, University of California, San Diego School of Medicine, La Jolla, CA, and approved July 22, 2009 (received for review October 6, 2008) Cells of the monocyte–macrophage lineage play a central role in the regulators (9). For instance, p50 and p52 homodimers act as orchestration and resolution of inflammation. Plasticity is a hallmark repressors because these proteins lack a transcription activation of mononuclear phagocytes, and in response to environmental sig- domain, present in RelA, RelB, v-Rel, and c-Rel (7). Accumulation nals these cells undergo different forms of polarized activation, the of p50 homodimers has been observed in endotoxin-tolerant mac- extremes of which are called classic or M1 and alternative or M2.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]